Beranda › Gagal Jantung › Georgia
Uji klinis Gagal Jantung di Georgia
28 studi untuk Gagal Jantung mencari peserta di lokasi di Georgia.
Kota di Georgia
- Atlanta25 studi
- Johns Creek5 studi
- Sandy Springs5 studi
- South Fulton4 studi
- Columbus3 studi
- Augusta3 studi
Teks studi resmi (Bahasa Inggris)
ELEVATE-HFpEF Clinical Study
- Emory University, Atlanta
Menerima peserta
Usia 40 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT06678841Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
- Research Site, Atlanta
- Research Site, Atlanta
- Research Site, Peachtree City
- dan 1 lainnya
Menerima pesertaFase 3
Usia 18 hingga 130 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT06307652A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
- Atlanta Clinical Research Centers, Atlanta
- NSC Research Inc, Johns Creek
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT06935370A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
- Atlanta Clinical Research Centers, Atlanta
- Columbus Regional Research Institute, Columbus
- NSC Research Inc, Johns Creek
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT06424288A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
- Research Site, Atlanta
- Research Site, Columbus
- Research Site, Tucker
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT07761117Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
- Grady Health System, Atlanta
- Piedmont Atlanta Hospital, Atlanta
- Emory Clinic, Atlanta
- dan 1 lainnya
Menerima pesertaFase 3
Usia 18 hingga 85 · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT06736574Alleviant ALLAY-HFrEF Study
- Atlanta VA Health Care System, Decatur
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 16 Sep 2026 · NCT06812533Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
- Piedmont Heart Institute, Atlanta
- Privia Medical Group Georgia LLC, Peachtree City
Menerima pesertaFase 3
Usia 18 hingga 99 · Semua jenis kelamin · Diperbarui 16 Sep 2026 · NCT07037459Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
- Research Site, Albany
- Research Site, Atlanta
- Research Site, Canton
- dan 5 lainnya
Menerima pesertaFase 3
Usia 40 ke atas · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT06677060A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)
- CON-10022 Atlanta, GA Investigational Site, Atlanta
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 10 Sep 2026 · NCT06024746A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
- Atlanta, GA Investigative Site 10022, Atlanta
- Duluth, GA Investigative Site 10083, Duluth
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 10 Sep 2026 · NCT06008197Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
- Piedmont Healthcare, Atlanta
- Emory University, Atlanta
Menerima peserta
Usia 18 hingga 100 · Semua jenis kelamin · Diperbarui 9 Sep 2026 · NCT06310031Safety and Effectiveness of Left Bundle Branch Area Pacing Versus Conventional Cardiac Resynchronization Therapy in Heart Failure
- Piedmont Hospital, Atlanta
- Emory University Hospital, Atlanta
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 4 Sep 2026 · NCT07069738Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
- Children's Healthcare of Atlanta - Arthur M. Blank Hospital ( Site 0001), Atlanta
Menerima pesertaFase 2/3
29 Days – 17 Years · Semua jenis kelamin · Diperbarui 28 Agu 2026 · NCT05714085Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
- Emory University Hospital, Atlanta
- Piedmont Healthcare Inc., Augusta
Menerima peserta
Usia 21 ke atas · Semua jenis kelamin · Diperbarui 25 Agu 2026 · NCT05677100Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
- Atlanta
Menerima pesertaStudi observasional
Semua usia · Semua jenis kelamin · Diperbarui 20 Agu 2026 · NCT00271180LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2
- Tenax Investigational Site, Athens
- Tenax Investigational Site, Atlanta
Menerima pesertaFase 3
Usia 18 hingga 85 · Semua jenis kelamin · Diperbarui 19 Agu 2026 · NCT07288398A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
- American Clinical Trials, LLC, Acworth
- Atlanta Center for Clinical Research_Atlanta, Atlanta
- East Atlanta Cardiology, Conyers
- dan 6 lainnya
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 18 Agu 2026 · NCT07567001Alleviant ALLAY-HF Study
- Atlanta VA Health Care System, Decatur
Menerima peserta
Usia 40 ke atas · Semua jenis kelamin · Diperbarui 14 Agu 2026 · NCT05685303CSP #2025 - Geriatric OUt-of-hospital Randomized MEal Trial in Heart Failure: Veterans Affairs (GOURMET-VA)
- Atlanta VA Medical and Rehab Center, Decatur, GA, Decatur
Menerima peserta
Usia 60 ke atas · Semua jenis kelamin · Diperbarui 14 Agu 2026 · NCT05996328A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction
- Emory University Hospital - Children's Healthcare of Atlanta Cardiology - Atlanta, Atlanta
Menerima pesertaFase 3
Hingga usia 18 · Semua jenis kelamin · Diperbarui 29 Jun 2026 · NCT07192952PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
- Piedmont, Atlanta
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 29 Jun 2026 · NCT05934487A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Placebo When Taken With Standard Treatment in Children With Heart Failure and Left Ventricular Systolic Dysfunction
- Emory University Hospital - Children's Healthcare of Atlanta Cardiology - Atlanta, Atlanta
Menerima pesertaFase 3
6 Months – 17 Years · Semua jenis kelamin · Diperbarui 15 Jun 2026 · NCT07188805Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
- Piedmont Heart Institute, Atlanta
- Piedmont Augusta Hospital, Augusta
- WellStar Kennestone Hospital, Marietta
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 10 Jun 2026 · NCT06526195XVIVO Heart Box (XHB) With Supplemented XVIVO Heart Solution (SXHS) Continued Access Protocol (CAP)
- Emory University Hospital, Atlanta
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 18 Mar 2026 · NCT06895070Sensor-based Congestion ALert for Events in Peritoneal Dialysis (SCALE-PD)
- Southeastern Clinical Research Institute, Augusta
Menerima pesertaStudi observasional
Usia 21 ke atas · Semua jenis kelamin · Diperbarui 18 Mar 2026 · NCT07059962Comparative Effectiveness of Carvedilol Versus Metoprolol Succinate in Heart Failure Patients With an Implantable Cardioverter Defibrillator
- AdventHealth Redmond, Rome
Menerima pesertaFase 4
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 18 Sep 2025 · NCT06964464AN INTERNATIONAL, OBSERVATIONAL, BLINDED STUDY TO ASSESS THE PERFORMANCE OF THE CORDIO HEARO SYSTEM
- West Georgia Cardiology, Carrollton
Menerima pesertaStudi observasional
Usia 22 ke atas · Semua jenis kelamin · Diperbarui 26 Mar 2025 · NCT06378632Dari ClinicalTrials.gov, data diambil 3 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.